Table 7.
Laboratory equipment and test availability, by health facility level
| On-site laboratory | Number of facilities with laboratory equipment or test | ||
|---|---|---|---|
| RRH (N = 13) n (%) | GH (N = 26) n (%) | HCIV (N = 14) n (%) | |
| 13 (100%) | 26 (100%) | 12 (86%) | |
| General tests | |||
| Hemoglobin | 12 (92.3) | 23 (88.5) | 11 (78.6) |
| Complete blood count and differential | 11 (84.6) | 19 (73.1) | 5 (35.7) |
| Electrolytes | 9 (69.2) | 10 (38.5) | 0 (0.0) |
| Renal function | 9 (69.2) | 13 (50.0) | 1 (7.1) |
| Liver function | 9 (69.2) | 11 (42.3) | 0 (0.0) |
| Lipid profile | 6 (46.2) | 8 (30.8) | 1 (7.1) |
| Urinalysis | 11 (84.6) | 25 (96.2) | 13 (92.9) |
| All of the above | 6 (46.2) | 6 (23.1) | 0 (0.0) |
| None of the above | 1 (7.7) | 0 (0.0) | 0 (0.0) |
| Diabetes tests | |||
| Random blood glucose | 12 (92.3) | 23 (88.5) | 14 (100.0) |
| Hemoglobin A1c | 0 (0.0) | 5 (19.2) | 0 (0.0) |
| Urine microalbumin | 4 (30.8) | 3 (11.5) | 0 (0.0) |
| All of the above | 0 (0.0) | 1 (3.8) | 0 (0.0) |
| None of the above | 1 (7.7) | 2 (7.7) | 0 (0.0) |
| Cancer tests | |||
| Cytology | 2 (15.4) | 3 (11.5) | 0 (0.0) |
| Fecal occult blood | 3 (23.1) | 4 (15.4) | 0 (0.0) |
| Prostate-Specific Antigen | 1 (7.7) | 2 (7.7) | 1 (7.1) |
| All of the above | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| None of the above | 8 (61.5) | 19 (73.1) | 13 (92.9) |
| Sickle cell disease tests | |||
| Hemoglobin electrophoresis | 0 (0.0) | 4 (15.4) | 0 (0.0) |
| Sickling test | 11 (84.6) | 21 (80.8) | 7 (50.0) |
| All of the above | 0 (0.0) | 2 (7.7) | 0 (0.0) |
| None of the above | 2 (15.4) | 4 (15.4) | 7 (50.0) |